DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
DH logo

Definitive Healthcare Corp. Stock Price

NasdaqGS:DH Community·US$149.2m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

DH Share Price Performance

US$1.03
-3.10 (-75.06%)
​
US$1.70
Fair Value
US$1.03
-3.10 (-75.06%)
39.4% undervalued intrinsic discount
US$1.70
Fair Value
Price US$1.03
AnalystConsensusTarget US$1.70
AnalystLowTarget US$1.00
AnalystHighTarget US$3.50
Wed, 12 Aug 26
Fair ValueUS$1.70
Share Pricen/a

DH Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$1.7 39.4% undervalued intrinsic discount

Healthcare Data Integration Will Broaden Future Addressable Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$1 3.0% overvalued intrinsic discount

Rising HIPAA Compliance And Cyber Threats Will Diminish Value

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$3.5 70.6% undervalued intrinsic discount

Secular AI And Digital Trends Will Unlock Healthcare Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
DH logo
Definitive Healthcare
39.4% undervalued intrinsic discount

Healthcare Data Integration Will Broaden Future Addressable Markets

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 12 Aug
Read Narrative
DH logo
Definitive Healthcare
70.6% undervalued intrinsic discount

Secular AI And Digital Trends Will Unlock Healthcare Potential

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 21 May
Read Narrative
DH logo
Definitive Healthcare
3.0% overvalued intrinsic discount

Rising HIPAA Compliance And Cyber Threats Will Diminish Value

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 5 May
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
DH logo

DH: Higher Future P/E And Product Updates Will Support Upside Potential

Fair Value: US$1.7 39.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
DH logo

DH: 2026 Guidance And Share Buyback Will Support Future Upside

Fair Value: US$3.5 70.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
DH logo

DH: Future Revenue Reset And Completed Buybacks Will Shape Entry Appeal

Fair Value: US$1 3.0% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet.

2 Risks
2 Rewards
View Full Analysis

Definitive Healthcare Corp. Key Details

US$232.7m

Revenue

US$37.8m

Cost of Revenue

US$194.9m

Gross Profit

US$363.1m

Other Expenses

-US$168.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.58
83.76%
-72.28%
85.5%
View Full Analysis

About DH

Founded
2011
Employees
682
CEO
Clay Ritchey
WebsiteView website
www.definitivehc.com

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Recent DH News & Updates

Recent updates

No updates

Definitive Healthcare Corp. Competitors

SBC logo

SBC Medical Group Holdings

Symbol: NasdaqGM:SBC
Market cap: US$445.8m
SGHT logo

Sight Sciences

Symbol: NasdaqGS:SGHT
Market cap: US$443.5m
CLPT logo

ClearPoint Neuro

Symbol: NasdaqCM:CLPT
Market cap: US$423.4m
PRE logo

Prenetics Global

Symbol: NasdaqGM:PRE
Market cap: US$411.1m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide